Search results
MAYNE PHARMA GROUP LIMITED. Market Cap $391.3M ! Add to my watchlist. Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... More. Synthetic anti-infective developer Recce Pharmaceuticals Ltd (ASX:RCE) has made inroads for recognition of its RECCE® 327 Gel (or R327G) as a topical treatment for burn wound ...
MAYNE PHARMA GROUP LIMITED. MYX. Click for more information. 0.66% $4.60. MAYNE PHARMA GROUP LIMITED - Announcements. Market Cap $391.3M! Add to my watchlist. Healthcare. Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused...Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company ...
MAYNE PHARMA GROUP LIMITED - Charts / Financials. Market Cap $390.4M ! Add to my watchlist. Healthcare. Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... More. Overview. Discussion. Corporate Spotlight.
Apr 6, 2024 · However i think MYX will dance to its own tune as per the news flow and fundamentals. MYX Price at posting: $6.72 Sentiment: Buy Disclosure: Held
Volume. $4.59. $4.84. $4.57. 44301. Last updated 15.59pm 01/10/2024 ? HotCopper has news, discussion, prices and market data on MAYNE PHARMA GROUP LIMITED. Join the HotCopper ASX share market forum today for free.
Jan 12, 2023 · MYX will not return to its formal heights on Mum and Dad investors; and fund managers look at fundamentals not discussions forms. Positive on MYX today was how quickly support flooded in when it hit the Intra-Day ($3.30) low. Fingers crossed we can see some support level starting to take shape so we don't have days of free falling...
Jan 27, 2023 · MYX SP has finally shot well above what he was expecting in record time! And secondly then the SP capitulates because now it has far further to fall after consolidation than what it ever would have if it hadn’t consolidated. MYX has been a total disaster for years unfortunately for all the retails caught up in SR’s legacy mess.
Jan 19, 2024 · Wish we could go back to MYX original growth going off shore into the Sates taking on MCS later developing it into a very profitable business plus state of the art manufacturing complex together with some large US pharma companies under contract using our services and then along came Nexstellis the initial cost plus all on going associated costs .
Oct 23, 2017 · The next company, Mayne Pharma (MYX) is another let-down merchant. It has 8.67% of its stock shorted but the following revelation is extraordinary! The Friday share price was $0.70 but its target price is, wait for it, $1.16. And if these professional company watchers are right, that will be a 64% rebound!
Feb 15, 2024 · Mithra's issues are well known - but MYX shareholders are also holding their breaths waiting for the next Nextstellis numbers (as really, this is a significant part of the company valuation), therefore there would be some caution with this movement. Very strong #'s for the unknown 2 months and the share price will fly. We have just over a week.
